Evidence map›Paper›PMID 29795336›Full record

ArticleCell death and differentiation2019

NFκB mitigates the pathological effects of misfolded α1-antitrypsin by activating autophagy and an integrated program of proteostasis mechanisms.

Amitava Mukherjee, Tunda Hidvegi, Patrick Araya, Michael Ewing, Donna B Stolz, David H Perlmutter

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Advances in Alpha-1 Antitrypsin Gene Therapy.American journal of respiratory cell and molecular biology · 2020
    Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Amitava MukherjeeDepartments of Pediatrics and Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Tunda HidvegiDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.
Patrick ArayaDepartments of Pediatrics and Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Michael EwingDepartments of Pediatrics and Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Donna B StolzDepartments of Pediatrics and Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
David H PerlmutterDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA. perlmutterd@wustl.edu.
University of Pittsburgh · USWashington University in St. Louis · US

Funding

Treating AT Deficiency with Drugs that Modulate the Proteostasis NetworkP01DK096990 · NIDDK · WASHINGTON UNIVERSITY · PI SILVERMAN, GARY ARTHUR · 2012 to 2023
$18.3M
Signaling Pathways Influencing Liver Disease Phenotype in Antitrypsin DeficiencyR01DK100289 · NIDDK · WASHINGTON UNIVERSITY · PI PERLMUTTER, DAVID H · 2014 to 2017
$1.8M
NIDDK NIH HHS P01 DK096990NIDDK NIH HHS R01 DK100289
6 · The paper itself

Abstract

Intrahepatocytic accumulation of misfolded α1-antitrypsin Z variant (ATZ) is responsible for liver disease in some individuals with α1-antitrypsin deficiency (ATD), characterized by fibrosis/cirrhosis and predisposition to carcinogenesis. Previous results showing that accumulation of ATZ in model systems activates the NFκB signaling pathway have led us to hypothesize that downstream targets of NFκB are elements of a proteostasis response network for this type of proteinopathy. Here we show that only a subset of downstream targets within the NFκB transcriptomic repertoire are activated in model systems of this proteinopathy. Breeding of the PiZ mouse model of ATD to two different mouse models with NFκB deficiency led to greater intrahepatocytic accumulation of ATZ, more severe hepatic fibrosis, decreased autophagy and hyperproliferation of hepatocytes with massive ATZ inclusions. Specific downstream targets of NFκB could be implicated in each pathological effect. These results suggest a new role for NFκB signaling in which specific downstream targets of this pathway mediate an integrated program of proteostatic responses designed to mitigate the pathologic effects of proteinopathy, including autophagic disposal of misfolded protein, degradation of collagen and prevention of hyperproliferation.

Indexed as

alpha 1-Antitrypsinalpha 1-Antitrypsin DeficiencyAnimalsAutophagyDown-RegulationEarly Growth Response Protein 1HeLa CellsHumansLiverMiceMice, Inbred C57BLMice, TransgenicNF-kappa BProtein FoldingProteostasisTranscriptomealpha 1-AntitrypsinEarly Growth Response Protein 1EGR1 protein, humanEgr1 protein, mouseNF-kappa B

Identifiers

PMID29795336
PMCPMC6370812
OpenAlexW2803148154

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.